962 related articles for article (PubMed ID: 32517663)
1. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
[TBL] [Abstract][Full Text] [Related]
3. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
[TBL] [Abstract][Full Text] [Related]
5. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
6. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2013 Aug; 130(2):264-8. PubMed ID: 23623831
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
[TBL] [Abstract][Full Text] [Related]
8. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.
Firnhaber C; Swarts A; Jezile V; Mulongo M; Goeieman B; Williams S; Faesen M; Michelow P; Wilkin T
Clin Infect Dis; 2021 Oct; 73(7):e2211-e2216. PubMed ID: 32975556
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.
Rabasa J; Bradbury M; Sanchez-Iglesias JL; Guerrero D; Forcada C; Alcalde A; Pérez-Benavente A; Cabrera S; Ramon-Cajal S; Hernandez J; Dinares C; García A; Centeno C; Gil-Moreno A
BJOG; 2020 Jan; 127(1):99-105. PubMed ID: 31502397
[TBL] [Abstract][Full Text] [Related]
11. HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model.
Fuste P; Bellosillo B; Santamaria X; Mancebo G; Mariñoso L; Alameda F; Espinet B; Sole F; Serrano S; Carreras R
Int J Gynecol Pathol; 2009 Mar; 28(2):120-6. PubMed ID: 19188824
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.
Greene SA; De Vuyst H; John-Stewart GC; Richardson BA; McGrath CJ; Marson KG; Trinh TT; Yatich N; Kiptinness C; Cagle A; Nyongesa-Malava E; Sakr SR; Mugo NR; Chung MH
JAMA; 2019 Oct; 322(16):1570-1579. PubMed ID: 31638680
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis.
Lichter K; Krause D; Xu J; Tsai SHL; Hage C; Weston E; Eke A; Levinson K
Obstet Gynecol; 2020 May; 135(5):1070-1083. PubMed ID: 32282601
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
16. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study for long-term oncologic and obstetric outcomes in cervical intraepithelial neoplasia treated with loop electrosurgical excision procedure: focus on surgical margin and human papillomavirus.
Cho A; Kim MY; Park IS; Park CM
BMC Womens Health; 2024 Feb; 24(1):116. PubMed ID: 38347568
[TBL] [Abstract][Full Text] [Related]
18. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
[No Abstract] [Full Text] [Related]
20. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
